Build Back Better Act Would Patch Holes in Health Coveragenews2021-12-01T10:00:25+00:00December 1st, 2021|The New York Times|
Inflation and Retirement: How to Protect Your Savingsnews2021-11-19T19:25:10+00:00November 19th, 2021|The New York Times|
Biogen’s Alzheimer’s drug is unlikely to win E.U. approval.news2021-11-18T04:32:41+00:00November 18th, 2021|The New York Times|
Democrats Reach Deal to Control Drug Prices in Billnews2021-11-02T23:14:56+00:00November 2nd, 2021|The New York Times|
Manchin Raises Doubts on Safety Net Bill, Complicating Path to Quick Votenews2021-11-01T23:14:05+00:00November 1st, 2021|The New York Times|
Why Aren’t More People Comparison Shopping for Health Plans?news2021-10-30T09:00:21+00:00October 30th, 2021|The New York Times|
This May Be Democrats’ Best Chance to Lower Drug Pricesnews2021-10-27T15:01:32+00:00October 27th, 2021|The New York Times|
Biden and Democrats Push for Budget Deal This Week as Rifts Remainnews2021-10-25T23:57:04+00:00October 25th, 2021|The New York Times|
Democrats’ Campaign to Control Drug Prices Nears Collapsenews2021-10-21T21:49:36+00:00October 21st, 2021|The New York Times|
Sales of Biogen’s Alzheimer’s Drug Fall Short of Expectationsnews2021-10-20T20:06:11+00:00October 20th, 2021|The New York Times|
